Nucleix's Angel Round

Nucleix raised a round of funding on , . Investors include Zohar Zisapel.

Nucleix develops, manufactures and markets non-invasive molecular cancer diagnostic tests. The company's sensitive and specific tests are based on identification of subtle changes in methylation patte…

Articles about Nucleix's Angel Round: